The legislature's own summary of the bill, or its official long title.
This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual.
Every action
7 steps, oldest first, as the legislature records them.
CommitteeIntroduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House · House Economic Development/Banking/Insurance & Commerce
CommitteeReported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits · House Economic Development/Banking/Insurance & Commerce
HousePassed By House. Votes: 39 YES 2 ABSENT39–0 vote
CommitteeAssigned to Banking, Business, Insurance & Technology Committee in Senate · Senate Banking, Business, Insurance & Technology
CommitteeReported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 1 Favorable, 5 On Its Merits · Senate Banking, Business, Insurance & Technology
SenatePassed By Senate. Votes: 21 YES
GovernorSigned by Governor
Roll calls
2 recorded votes: 2 on the floor, 0 in committee. Each shows how every member voted.
Passed By House. Votes: 39 YES 2 ABSENT · Full House